Ascendis Pharma A/S
ASND
9 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Dec 10 9:44 PM | MIKKELSEN JAN MOLLER | Proposed Sale | 5,292 | $129.13 | $683.3K | — | View → |
| Dec 3, 2024 | Dec 3 9:35 PM | JENSEN FLEMMING STEEN | Proposed Sale | 9,375 | $131.37 | $1.2M | — | View → |
| Nov 19, 2024 | Nov 19 9:08 PM | Hartvig Camilla Harder | Proposed Sale | 19,468 | $122.38 | $2.4M | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Sep 28 8:08 PM | Jean Jacques BienaimeDirector | Grant/Award | 9,160 | $249.84 | 9,160(D) | View → |
| Apr 14, 2026 | Sep 28 8:08 PM | Jean Jacques BienaimeDirector | Disposition | 9,160 | $172.35 | 0(D) | View → |
| Sep 8, 2026 | Sep 9 9:04 PM | Mads BodenhoffSVP & PAO | Option Exercise | 3,000 | $110.00 | 687(D) | View → |